By Karen Roman Winemaker The Duckhorn Portfolio, Inc. (NYSE: NAPA) said it will be taken private in an all-cash deal worth $1.95 billion by Butterfly Equity, in a transaction expected to conclude this winter. The private equity firm agreed to...

By Karen Roman Eliem Therapeutics, Inc. (Nasdaq: ELYM) said its new corporate name will be Climb Bio, Inc. and it will start trading at Nasdaq with the ticker symbol “CLYM” on Oct. 3. This rebranding reflects Climb’s laser-focused mission on...

Republicans’ attempt to ban TikTok is a ‘self-own,’ says the former Trump staffer, whose TikTok stardom is a blueprint for how a new generation of voters – and consumers – can be influenced. By Exec Edge Editorial Staff John McEntee...

By Karen Roman Aktis Oncology said it raised $175 million in Series B financing, led by RA Capital Management, with RTW Investments and Janus Henderson Investors as co-leads. The capital will contribute to the company’s radiopharmaceuticals pipeline including AKY-1189, its...

By Daniella Parra Vivani Medical said it received regulatory approval in Australia for its GLP-1 (exenatide) implant, aimed at treating obese and overweight individuals. The trial will evaluate the safety, tolerability and pharmacokinetic profile of the implant, which is designed...

Tech Edge hosted a fireside chat on Sept. 12 at Nasdaq MarketSite with Erik Carlson, Chief Operating Officer at Notified. The in-person interview was joined by Editor-at-Large Jarrett Banks and they discussed the company’s partnership with CLEAR and its integration into the GlobeNewswire...

Tech Edge hosted a fireside chat on Sept. 12 at Nasdaq MarketSite with Mario Carvajal, Chief Marketing and Chief Strategy Officer of AvePoint, Inc. (Nasdaq: AVPT). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed the company’s earnings, “cyber...

By Karen Roman 65 Equity Partners said it completed a minority investment in lifestyle and accessories brand Kendra Scott Design. The partnership will contribute to the brand’s cultural collaborations and global expansion into new categories, it said in a statement....

By Daniella Parra Agendia said its FLEX Study has enrolled over 17,000 early-stage breast cancer patients from diverse ethnic and racial backgrounds, aiming to address racial and ethnic disparities in breast cancer treatment. The study is a large-scale, real-world evidence,...

By Karen Roman Kineticos Life Sciences said it has partnered with Orthobond, a biotechnology company focused on medical devices, through investment from the Kineticos AMR Accelerator Fund I. Kineticos strategic advisor Steve Favaloro will be joining Orthobond’s Board of Directors,...